NABRIVA

Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections... Nabriva is a commercial-stage biopharmaceutical company engaged in the research development of novel antibiotics to treat serious infections, with a current focus on the pleuromutilin class of antibiotics. Learn more at Nabriva.com... Our goal is to become a fully integrated biopharmaceutical company focused on the development and commercialization of new antibiotics and other novel anti-infective products.

Also known as: Nabriva Therapeutics, Nabriva Therapeutics GmbH, Nabriva Therapeutics plc, Nabriva Therapeutics US, Inc., Nabriva US

VAT numbers: 3514827BH, ATU62319422

Primary location: Vienna Austria